- Home
- ADT vs LNTH Comparison
ADT vs LNTH Comparison
Compare ADT & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADT
- LNTH
- Stock Information
- Founded
- ADT 1874
- LNTH 1956
- Country
- ADT United States
- LNTH United States
- Employees
- ADT N/A
- LNTH N/A
- Industry
- ADT Diversified Commercial Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ADT Consumer Discretionary
- LNTH Health Care
- Exchange
- ADT Nasdaq
- LNTH Nasdaq
- Market Cap
- ADT 6.3B
- LNTH 6.0B
- IPO Year
- ADT 2018
- LNTH 2015
- Fundamental
- Price
- ADT $7.35
- LNTH $78.23
- Analyst Decision
- ADT Hold
- LNTH Strong Buy
- Analyst Count
- ADT 4
- LNTH 6
- Target Price
- ADT $8.55
- LNTH $132.67
- AVG Volume (30 Days)
- ADT 6.2M
- LNTH 832.8K
- Earning Date
- ADT 02-27-2025
- LNTH 02-26-2025
- Dividend Yield
- ADT 3.00%
- LNTH N/A
- EPS Growth
- ADT 2041.84
- LNTH 304.57
- EPS
- ADT 0.98
- LNTH 6.02
- Revenue
- ADT $5,140,300,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- ADT N/A
- LNTH $19.64
- Revenue Next Year
- ADT $4.36
- LNTH $5.16
- P/E Ratio
- ADT $7.51
- LNTH $12.99
- Revenue Growth
- ADT 7.14
- LNTH 24.15
- 52 Week Low
- ADT $6.10
- LNTH $56.44
- 52 Week High
- ADT $8.25
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- ADT 46.77
- LNTH 31.32
- Support Level
- ADT $7.36
- LNTH $79.39
- Resistance Level
- ADT $7.67
- LNTH $84.24
- Average True Range (ATR)
- ADT 0.18
- LNTH 3.84
- MACD
- ADT -0.03
- LNTH -0.93
- Stochastic Oscillator
- ADT 9.71
- LNTH 0.66
About ADT ADT Inc.
ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. It offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. The company segments include Consumer and Small Business (CSB), Commercial, and Solar. It generates maximum revenue from the Commercial segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.